Table 2. Demographics, clinical characteristics and source of Infection of 71 patients at the time of diagnosis.

	PersistentPIGN (n = 42)	HealedPIGN (n = 28)	P-value
Sex
Male (%)	27 (64)	17 (61)	0.8
Female (%)	15 (36)	11 (39)
Age (median, IQR)	45 (41, 52)	48.5 (42, 54.5)	0.47
Race - no. of patients (%)
Black	38 (91)	24 (86)	0.41
White	2 (5)	4 (14)
Asian	1 (2)	0 (0.00)
Others	1 (2)	0 (0.00)
Serum creatinine (Median, IQR)	2.2 (1.1, 4.9)	2.6 (1.9, 5.1)	0.31
CD4 count (Median, IQR)	327 (199, 506)	238 (77, 459)	0.26
Comorbidities - no. of patients (%)
Diabetes	11 (28)	6 (23)	0.8
Hypertension	35 (88)	22 (79)	0.34
Hepatitis C	24 (63)	14 (56)	0.61
Cirrhosis	1 (3)	2 (7)	0.57
Malignancy	8 (21)	3 (11)	0.34
Other systemic diseases	5 (13)	5 (20)	0.5
Intravenous drug use	19 (50)	10 (42)	0.61
Low C3	8 (25)	2 (10)	0.28
Low C4	8 (25)	2 (10)	0.28
Site of Infection –no. of patients (%)
Endocardium	12 (29)	4 (14)	0.59
Bone/Joint	1 (2)	2 (7)
Pleura	1 (2)	0 (0)
Skin	4 (10)	4 (14)
Lung/URTI	6 (14)	5 (18)
Others	2 (5)	0 (0.00)
None identified	16 (38)	14 (50)
Infectious Agent – no. of patients (%)	N = 26	N = 25
Staphylococcus	11 (42)	14 (56)	0.31
Streptococcus	7 (27)	8 (32)
Others	8 (31)	3 (12)
HIV medications – no. of patients (%)
NRTI	21 (66)	11 (78)	0.5
NNRTI	7 (22)	2 (14)	0.7
PI	19 (59)	8 (57)	1
Other medications – no. of patients (%)
ACE Inhibitors	19 (50)	12 (46)	0.8
ARB	1 (3)	1 (4)	1
Corticosteroid	9 (23)	3 (11)	0.51
Antibiotic use	24 (62)	16 (62)	0.92
Nephrotic Proteinuria	8 (26)	11 (46)	0.16
Hematuria	23 (62)	8 (30)	0.02